188 related articles for article (PubMed ID: 32328966)
1. High rate incidence of post-surgical adverse events in patients with low-risk papillary thyroid cancer who did not accept active surveillance.
Smulever A; Pitoia F
Endocrine; 2020 Sep; 69(3):587-595. PubMed ID: 32328966
[TBL] [Abstract][Full Text] [Related]
2. Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery.
Oda H; Miyauchi A; Ito Y; Yoshioka K; Nakayama A; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Thyroid; 2016 Jan; 26(1):150-5. PubMed ID: 26426735
[TBL] [Abstract][Full Text] [Related]
3. Applying Criteria of Active Surveillance to Low-Risk Papillary Thyroid Cancer Over a Decade: How Many Surgeries and Complications Can Be Avoided?
Griffin A; Brito JP; Bahl M; Hoang JK
Thyroid; 2017 Apr; 27(4):518-523. PubMed ID: 28125944
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Postoperative Unfavorable Events in Patients with Low-Risk Papillary Thyroid Carcinoma: Immediate Surgery Versus Conversion Surgery Following Active Surveillance.
Sasaki T; Miyauchi A; Fujishima M; Ito Y; Kudo T; Noda T; Sano T; Kishi T; Nakamura T
Thyroid; 2023 Feb; 33(2):186-191. PubMed ID: 36205580
[No Abstract] [Full Text] [Related]
5. Trends of the prevalence rate of central lymph node metastasis and multifocality in patients with low-risk papillary thyroid carcinoma after delayed thyroid surgery.
Wang P; Dong Z; Zhao S; Su Y; Zhang J; Ma Y; Diao C; Qian J; Cheng R; Liu W
Front Endocrinol (Lausanne); 2024; 15():1349272. PubMed ID: 38638135
[TBL] [Abstract][Full Text] [Related]
6. Insights into the Management of Papillary Microcarcinoma of the Thyroid.
Miyauchi A; Ito Y; Oda H
Thyroid; 2018 Jan; 28(1):23-31. PubMed ID: 28629253
[TBL] [Abstract][Full Text] [Related]
7. Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the Thyroid.
Miyauchi A
World J Surg; 2016 Mar; 40(3):516-22. PubMed ID: 26744340
[TBL] [Abstract][Full Text] [Related]
8. Active surveillance in small cytological indeterminate thyroid nodules: a call to common sense?
Smulever A; Pitoia F
Endocrine; 2021 May; 72(2):505-512. PubMed ID: 33411327
[TBL] [Abstract][Full Text] [Related]
9. Experience with Active Surveillance of Thyroid Low-Risk Carcinoma in a Developing Country.
Sanabria A
Thyroid; 2020 Jul; 30(7):985-991. PubMed ID: 31950887
[No Abstract] [Full Text] [Related]
10. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
[TBL] [Abstract][Full Text] [Related]
11. Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America.
Smulever A; Pitoia F
Arch Endocrinol Metab; 2019; 63(5):462-469. PubMed ID: 31482955
[TBL] [Abstract][Full Text] [Related]
12. Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials.
Ito Y; Miyauchi A; Oda H
Eur J Surg Oncol; 2018 Mar; 44(3):307-315. PubMed ID: 28343733
[TBL] [Abstract][Full Text] [Related]
13. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
14. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices.
Trésallet C; Seman M; Tissier F; Buffet C; Lupinacci RM; Vuarnesson H; Leenhardt L; Menegaux F
Surgery; 2014 Nov; 156(5):1145-52. PubMed ID: 24878452
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of central neck dissection for cN0 papillary thyroid carcinoma.
Giordano D; Frasoldati A; Gabrielli E; Pernice C; Zini M; Castellucci A; Piana S; Ciarrocchi A; Cavuto S; Barbieri V
Am J Otolaryngol; 2017; 38(5):576-581. PubMed ID: 28599790
[TBL] [Abstract][Full Text] [Related]
16. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity?
Alvarado R; Sywak MS; Delbridge L; Sidhu SB
Surgery; 2009 May; 145(5):514-8. PubMed ID: 19375610
[TBL] [Abstract][Full Text] [Related]
17. Cervical Lymph Node Metastases After Thyroidectomy for Papillary Thyroid Carcinoma Usually Remain Stable for Years.
Tomoda C; Sugino K; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Ito K
Thyroid; 2016 Dec; 26(12):1706-1711. PubMed ID: 27616725
[TBL] [Abstract][Full Text] [Related]
18. Serial Neck Ultrasonographic Evaluation of Changes in Papillary Thyroid Carcinoma During Pregnancy.
Oh HS; Kim WG; Park S; Kim M; Kwon H; Jeon MJ; Lee JH; Baek JH; Song DE; Kim TY; Shong YK; Kim WB
Thyroid; 2017 Jun; 27(6):773-777. PubMed ID: 28446078
[TBL] [Abstract][Full Text] [Related]
19. Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan.
Sugitani I; Ito Y; Miyauchi A; Imai T; Suzuki S
Thyroid; 2019 Nov; 29(11):1563-1571. PubMed ID: 31441377
[No Abstract] [Full Text] [Related]
20. Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma.
Sakai T; Sugitani I; Ebina A; Fukuoka O; Toda K; Mitani H; Yamada K
Thyroid; 2019 Jan; 29(1):59-63. PubMed ID: 30560718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]